NHS: Drugs

(asked on 18th April 2018) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that patients can promptly access drugs if the UK is no longer a member of the European Medicines Agency during any transition period after the UK leaves the EU.


Answered by
Jackie Doyle-Price Portrait
Jackie Doyle-Price
This question was answered on 23rd April 2018

During the implementation period, the United Kingdom will no longer be a Member State of the European Union, but market access will continue on current terms. We will continue to have access to drugs at the same time as countries within the EU, and the UK will continue to participate in and have access to European Medicines Agency (EMA).

In regard to the future relationship, the Prime Minister's Mansion House speech outlined that we will also explore the terms on which the UK could remain part of the EMA. While it would not be appropriate to pre-judge the outcome of the negotiations we will discuss with the EU and Member States how best to continue cooperation in medicines regulation.

Reticulating Splines